Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | KRT16 |
| Upstream (Parents) |
|---|
| (<<) ACTN4 → KRT16 |
| (<<) ANGPTL4 → KRT16 |
| (<<) CNFN → KRT16 |
| (<<) DUSP4 → KRT16 |
| (<<) DUSP6 → KRT16 |
| (<<) EMP1 → KRT16 |
| (<<) ENO2 → KRT16 |
| (<<) HDAC5 → KRT16 |
| (<<) KRT5 → KRT16 |
| (<<) LEMD1 → KRT16 |
| (<<) MLPH → KRT16 |
| (<<) MMP7 → KRT16 |
| (<<) SFN → KRT16 |
| (<<) SPRR1B → KRT16 |
| (<<) VEGFA → KRT16 |
| Downstream (Children) |
|---|
| KRT16 → ACAT2 (>>) |
| KRT16 → ARHGEF4 (>>) |
| KRT16 → ASNS (>>) |
| KRT16 → ATP2B1 (>>) |
| KRT16 → BBS1 (>>) |
| KRT16 → CDKN2A (>>) |
| KRT16 → CHST3 (>>) |
| KRT16 → CPD (>>) |
| KRT16 → FERMT1 (>>) |
| KRT16 → FOXQ1 (>>) |
| KRT16 → GPRIN2 (>>) |
| KRT16 → KCNG1 (>>) |
| KRT16 → KLK10 (>>) |
| KRT16 → KLK5 (>>) |
| KRT16 → KLK7 (>>) |
| KRT16 → KLK8 (>>) |
| KRT16 → KRT14 (>>) |
| KRT16 → KRT6B (>>) |
| KRT16 → LYNX1 (>>) |
| KRT16 → NDRG1 (>>) |
| KRT16 → NFIA (>>) |
| KRT16 → PCSK1N (>>) |
| KRT16 → PTPLA (>>) |
| KRT16 → S100A2 (>>) |
| KRT16 → SERPINB2 (>>) |
| KRT16 → SERPINB5 (>>) |
| KRT16 → SMOX (>>) |
| KRT16 → STC2 (>>) |
| KRT16 → TRERF1 (>>) |
| KRT16 → UCA1 (>>) |
